Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for noncommunicable diseases

Mettraux C.; Gilmoor A.; Ewen M.; Besançon S.; Giachino M.; Laurson-Doube J.; Lepeska M.; Macé C.; Perrin C.; Mucha J.T.; Turkie R.; Beran D. · BMJ Global Health (2025) · DOI: 10.1136/bmjgh-2025-019355

Instituciones: Universidad Peruana Cayetano Heredia